Our company’s regional nurse came to my facility and said we were going to start using insulin pens. Can you tell me what I should prepare for? It is great that you want to get a head start on ...
Please provide your email address to receive an email when new articles are posted on . The FDA clarified the intent of November 2019 revisions to labeling for insulin pens that state that health care ...
As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...
If you happen to use an insulin pen or are thinking of starting on one, don’t forget to pay attention to your choice of tiny needles that are screwed on to the top of the pen device. These small sharp ...
Credit: Getty Images. The recall does not pertain to the interchangeable biosimilars, Semglee (insulin glargine-yfgn) injection, or Insulin Glargine (insulin glargine-yfgn) injection. Mylan ...
A smart insulin pen may not be the rarest sighting in diabetes these days, but Bigfoot Biomedical aims to stand apart with a new FDA clearance for delivery devices that provide real-time alerts for ...
March 19, 2009 — Insulin pens and cartridges should not be used in multiple patients because of the risk for transmission of blood-borne pathogens, the US Food and Drug Administration (FDA) announced ...
CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and ...
As insulin pens often have similar appearances and are not labeled for dispensing as individual units, the carton helps both healthcare professionals and patients distinguish between the products.
MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir).
The US Food and Drug Administration (FDA) is advising clinicians to dispense insulin pens in their original sealed cartons to a single diabetes patient. The new notice states that these products ...
(RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results